share_log

Johnson & Johnson | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Johnson & Johnson | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

强生 | FWP：自由书写募资说明书
美股sec公告 ·  05/14 06:10
Moomoo AI 已提取核心信息
Johnson & Johnson has announced the pricing of a series of notes with varying maturities and interest rates, as detailed in a pricing term sheet filed on May 13, 2024. The offering includes 4.800% notes due 2029, 4.900% notes due 2031, 4.950% notes due 2034, and 5.250% notes due 2054, with a total size of $4 billion. The notes will pay semi-annual interest starting December 1, 2024, and are priced close to par with slight discounts. The proceeds from the sale, along with other funds, are intended to finance the acquisition of Shockwave Medical, Inc., which is contingent on shareholder and regulatory approvals. The offering is managed by a syndicate of banks, including J.P. Morgan Securities LLC and BofA Securities, Inc. as joint book-running managers. The expected settlement date for the notes is May 20, 2024.
Johnson & Johnson has announced the pricing of a series of notes with varying maturities and interest rates, as detailed in a pricing term sheet filed on May 13, 2024. The offering includes 4.800% notes due 2029, 4.900% notes due 2031, 4.950% notes due 2034, and 5.250% notes due 2054, with a total size of $4 billion. The notes will pay semi-annual interest starting December 1, 2024, and are priced close to par with slight discounts. The proceeds from the sale, along with other funds, are intended to finance the acquisition of Shockwave Medical, Inc., which is contingent on shareholder and regulatory approvals. The offering is managed by a syndicate of banks, including J.P. Morgan Securities LLC and BofA Securities, Inc. as joint book-running managers. The expected settlement date for the notes is May 20, 2024.
强生公司宣布了一系列不同期限和利率的票据的定价，详见2024年5月13日提交的定价条款表。此次发行包括2029年到期的4.800％的票据、2031年到期的4.900％的票据、2034年到期的4.950％的票据以及2054年到期的5.250％的票据，总规模为40亿美元。这些票据将从2024年12月1日起支付半年利息，价格接近平均水平，略有折扣。出售所得款项以及其他资金旨在为收购Shockwave Medical, Inc. 提供资金，这取决于股东和监管部门的批准。此次发行由银行集团管理，其中包括作为联席账面运营经理的摩根大通证券有限责任公司和美银证券公司。这些票据的预计结算日期为2024年5月20日。
强生公司宣布了一系列不同期限和利率的票据的定价，详见2024年5月13日提交的定价条款表。此次发行包括2029年到期的4.800％的票据、2031年到期的4.900％的票据、2034年到期的4.950％的票据以及2054年到期的5.250％的票据，总规模为40亿美元。这些票据将从2024年12月1日起支付半年利息，价格接近平均水平，略有折扣。出售所得款项以及其他资金旨在为收购Shockwave Medical, Inc. 提供资金，这取决于股东和监管部门的批准。此次发行由银行集团管理，其中包括作为联席账面运营经理的摩根大通证券有限责任公司和美银证券公司。这些票据的预计结算日期为2024年5月20日。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息